Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways

Over 50 genetic variants have been statistically associated with the development of SLE (or lupus). Each genetic association is a key component of a pathway to lupus pathogenesis, the majority of which requires further mechanistic studies to understand the functional changes to cellular physiology. Whereas their use in clinical practice has yet to be established, these genes guide efforts to develop more specific therapeutic approaches. The BCR signaling pathways are rich in lupus susceptibility genes and may well provide novel opportunities for the understanding and clinical treatment of this complex disease.

[1]  B. Tsao,et al.  Recent insights into the genetic basis of systemic lupus erythematosus , 2012, Annals of the rheumatic diseases.

[2]  P. Gaffney,et al.  Evaluation of TRAF6 in a large multiancestral lupus cohort. , 2012, Arthritis and rheumatism.

[3]  R. Maciuca,et al.  Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. , 2012, Arthritis and rheumatism.

[4]  V. Dixit,et al.  Regulation of NF‐κB by deubiquitinases , 2012, Immunological reviews.

[5]  L. Truedsson,et al.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene , 2012, Genes and Immunity.

[6]  E. Lander,et al.  The mystery of missing heritability: Genetic interactions create phantom heritability , 2012, Proceedings of the National Academy of Sciences.

[7]  E. L. Luning Prak,et al.  Altered B Cell Homeostasis Is Associated with Type I Diabetes and Carriers of the PTPN22 Allelic Variant , 2012, The Journal of Immunology.

[8]  Don L. Armstrong,et al.  Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase , 2011, Proceedings of the National Academy of Sciences.

[9]  A. DeFranco,et al.  Elevated BCR signaling and decreased survival of Lyn‐deficient transitional and follicular B cells , 2011, European journal of immunology.

[10]  S. Pillai,et al.  B cells and autoimmunity. , 2011, Current opinion in immunology.

[11]  Raphael Zidovetzki,et al.  A Comprehensive Analysis of Shared Loci between Systemic Lupus Erythematosus (SLE) and Sixteen Autoimmune Diseases Reveals Limited Genetic Overlap , 2011, PLoS genetics.

[12]  M. Petri,et al.  A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[13]  Jin He,et al.  Direct, noncatalytic mechanism of IKK inhibition by A20. , 2011, Molecular cell.

[14]  B. Su,et al.  Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population , 2011, Arthritis research & therapy.

[15]  P. Gaffney,et al.  Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. , 2011, Arthritis and rheumatism.

[16]  Sarah Edkins,et al.  Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease , 2011, Nature Genetics.

[17]  A. Syvänen,et al.  Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus , 2011, PLoS genetics.

[18]  R. Toes,et al.  A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis , 2011, Annals of the rheumatic diseases.

[19]  S. Kozyrev,et al.  The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization , 2011, Genes and Immunity.

[20]  P. Gregersen,et al.  The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. , 2011, The Journal of clinical investigation.

[21]  E. Harhaj,et al.  ABIN1 Protein Cooperates with TAX1BP1 and A20 Proteins to Inhibit Antiviral Signaling* , 2011, The Journal of Biological Chemistry.

[22]  P. Cohen,et al.  Polyubiquitin binding to ABIN1 is required to prevent autoimmunity , 2011, The Journal of experimental medicine.

[23]  A. Tanaka,et al.  Receptors, subcellular compartments and the regulation of peripheral B cell responses: the illuminating state of anergy. , 2011, Molecular immunology.

[24]  Nan Shen,et al.  A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus , 2011, PLoS genetics.

[25]  P. Gaffney,et al.  Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. , 2011, Arthritis and rheumatism.

[26]  T. Niewold,et al.  Interferon regulatory factors in human lupus pathogenesis. , 2011, Translational research : the journal of laboratory and clinical medicine.

[27]  P. Gaffney,et al.  Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort , 2011, Genes and Immunity.

[28]  D. Ye,et al.  The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta‐analysis , 2011, International journal of immunogenetics.

[29]  Liangdan Sun,et al.  Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. , 2011, Rheumatology.

[30]  M. Guan,et al.  The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population , 2011, Clinical Rheumatology.

[31]  P. Gregersen,et al.  Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus , 2011, Nature Genetics.

[32]  P. Sham,et al.  Two missense variants in UHRF1BP1 are independently associated with systemic lupus erythematosus in Hong Kong Chinese , 2011, Genes and Immunity.

[33]  K. Amann,et al.  B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. , 2011, Blood.

[34]  E. Lander.  Initial impact of the sequencing of the human genome , 2011, Nature.

[35]  P. Sham,et al.  ELF1 is associated with systemic lupus erythematosus in Asian populations. , 2011, Human molecular genetics.

[36]  P. Gaffney,et al.  Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function , 2011, Autoimmunity.

[37]  P. Gregersen,et al.  Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. , 2011, American journal of human genetics.

[38]  Y.H. Lee,et al.  The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update , 2011, Lupus.

[39]  B. Tsao,et al.  Genetic susceptibility to systemic lupus erythematosus in the genomic era , 2010, Nature Reviews Rheumatology.

[40]  J. Cerhan,et al.  A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling , 2010, The Journal of experimental medicine.

[41]  T. Behrens,et al.  Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study , 2010, Arthritis research & therapy.

[42]  Liangdan Sun,et al.  Polymorphisms at 16p13 are associated with systemic lupus erythematosus in the Chinese population , 2010, Journal of Medical Genetics.

[43]  C. Liu,et al.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. , 2010, Immunity.

[44]  R. Cantor,et al.  Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus , 2010, Proceedings of the National Academy of Sciences.

[45]  A. DeFranco,et al.  Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice , 2010, The Journal of experimental medicine.

[46]  E. Adams,et al.  African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity , 2010, The Journal of Immunology.

[47]  Nunzio Bottini,et al.  Autoimmune-associated PTPN22 R620W Variation Reduces Phosphorylation of Lymphoid Phosphatase on an Inhibitory Tyrosine Residue* , 2010, The Journal of Biological Chemistry.

[48]  B. Chiang,et al.  Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients , 2010, Lupus.

[49]  Liangdan Sun,et al.  TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population , 2010, Lupus.

[50]  Constantin Polychronakos,et al.  Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. , 2010, Human molecular genetics.

[51]  J. Whittaker,et al.  Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus , 2010, European Journal of Human Genetics.

[52]  I. Wertz,et al.  A20: from ubiquitin editing to tumour suppression , 2010, Nature Reviews Cancer.

[53]  F. Tsai,et al.  IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. , 2010, Clinical and experimental rheumatology.

[54]  J. Pagano,et al.  The A20 Deubiquitinase Activity Negatively Regulates LMP1 Activation of IRF7 , 2010, Journal of Virology.

[55]  Yoshihiro Baba,et al.  B cell signaling and fate decision. , 2010, Annual review of immunology.

[56]  J. Ioannidis,et al.  Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies , 2010, European Journal of Human Genetics.

[57]  Javier Martín,et al.  Promoter Insertion/Deletion in the IRF5 Gene Is Highly Associated with Susceptibility to Systemic Lupus Erythematosus in Distinct Populations, But Exerts a Modest Effect on Gene Expression in Peripheral Blood Mononuclear Cells , 2010, The Journal of Rheumatology.

[58]  K. Duffin,et al.  Genetic variations associated with psoriasis and psoriatic arthritis found by genome‐wide association , 2010, Dermatologic therapy.

[59]  D. Ye,et al.  A meta-analysis of the association of STAT4 polymorphism with systemic lupus erythematosus , 2010, Modern rheumatology.

[60]  P. Sham,et al.  Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus , 2010, PLoS genetics.

[61]  Annette Lee,et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus , 2009, Nature Genetics.

[62]  Ying Wang,et al.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.

[63]  P. Gaffney,et al.  High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions , 2009, PLoS genetics.

[64]  M. Calaza,et al.  Replication of recently identified systemic lupus erythematosus genetic associations: a case–control study , 2009, Arthritis research & therapy.

[65]  C. Langefeld,et al.  Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies , 2009, Nature Reviews Genetics.

[66]  E. L. Prak,et al.  Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance1 , 2009, The Journal of Immunology.

[67]  P. Gaffney,et al.  Genetic associations of LYN with systemic lupus erythematosus , 2009, Genes and Immunity.

[68]  P. Gaffney,et al.  Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population , 2009, Genes and Immunity.

[69]  P. Gaffney,et al.  Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[70]  Don L. Armstrong,et al.  High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. , 2009, Arthritis and rheumatism.

[71]  M. Hermiston,et al.  PTPN22 Deficiency Cooperates with the CD45 E613R Allele to Break Tolerance on a Non-Autoimmune Background1 , 2009, The Journal of Immunology.

[72]  J. Molineros,et al.  Admixture in Hispanic-Americans: Its impact on ITGAM association and implications for admixture mapping in SLE , 2009, Genes and Immunity.

[73]  T. Habib,et al.  Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signaling1 , 2009, The Journal of Immunology.

[74]  J. Todd,et al.  Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus , 2009, Genes and Immunity.

[75]  M Bruinenberg,et al.  Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling , 2009, Gut.

[76]  T. Behrens,et al.  Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population. , 2009, Arthritis and rheumatism.

[77]  J. Harley,et al.  Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. , 2008, Journal of autoimmunity.

[78]  N. Eriksson,et al.  STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk , 2008, Annals of the rheumatic diseases.

[79]  K. Rajewsky,et al.  Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. , 2008, Immunity.

[80]  M. Daly,et al.  Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[81]  Pui-Yan Kwok,et al.  Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus , 2008, Nature Genetics.

[82]  Yaofeng Zhao,et al.  PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis , 2008, Journal of Neuroimmunology.

[83]  T. Witte.  IgM Antibodies Against dsDNA in SLE , 2008, Clinical reviews in allergy & immunology.

[84]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[85]  M. Petri,et al.  Genetic variation in the CRP promoter: association with systemic lupus erythematosus. , 2008, Human molecular genetics.

[86]  L. Milani,et al.  Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. , 2008, Human molecular genetics.

[87]  Shizhong Han,et al.  Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus , 2008, PloS one.

[88]  Geoffrey Hom,et al.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.

[89]  Bettina L. Lee,et al.  Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20 , 2008, The Journal of experimental medicine.

[90]  Sandra D'Alfonso,et al.  Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[91]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[92]  Wei Chen,et al.  A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus , 2008, Nature Genetics.

[93]  D. Strachan,et al.  Rheumatoid arthritis association at 6q23 , 2007, Nature Genetics.

[94]  S. Gabriel,et al.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis , 2007, Nature Genetics.

[95]  R. Cornall,et al.  MyD88‐dependent autoimmune disease in Lyn‐deficient mice , 2007, European journal of immunology.

[96]  P. Concannon,et al.  Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes1 , 2007, The Journal of Immunology.

[97]  Wentian Li,et al.  STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. , 2007, The New England journal of medicine.

[98]  J. Lieberman,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.

[99]  J. Harley.  IL-7Rα and multiple sclerosis risk , 2007, Nature Genetics.

[100]  A. Syvänen,et al.  Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[101]  M. Tanimoto,et al.  Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors. , 2006, International journal of molecular medicine.

[102]  F. Chen,et al.  Finding NEMO by K63-linked polyubiquitin chain , 2006, Cell Death and Differentiation.

[103]  A. Dinner,et al.  B Cell Antigen Receptor Signaling and Internalization Are Mutually Exclusive Events , 2006, PLoS biology.

[104]  Marta E Alarcón-Riquelme,et al.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.

[105]  H. Sanjo,et al.  BANK negatively regulates Akt activation and subsequent B cell responses. , 2006, Immunity.

[106]  J. Jais,et al.  Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis , 2006, Annals of neurology.

[107]  D. Isenberg,et al.  Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[108]  Nunzio Bottini,et al.  Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant , 2005, Nature Genetics.

[109]  Marta E Alarcón-Riquelme,et al.  Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. , 2005, Arthritis and rheumatism.

[110]  J. Kere,et al.  Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. , 2005, American journal of human genetics.

[111]  Adrian Vella,et al.  Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. , 2004, Diabetes.

[112]  A. Cappione,et al.  Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[113]  Y. Shoenfeld,et al.  Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. , 2004, Seminars in arthritis and rheumatism.

[114]  Kristin G Ardlie,et al.  Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. , 2004, American journal of human genetics.

[115]  Steven J. Schrodi,et al.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.

[116]  I. Sanz,et al.  B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. , 2004, Arthritis and rheumatism.

[117]  J. D. Dal Porto,et al.  B cell antigen receptor signaling 101. , 2004, Molecular immunology.

[118]  Suk-Kyeong Lee,et al.  Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood , 2004, Arthritis research & therapy.

[119]  Nunzio Bottini,et al.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.

[120]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[121]  Thomas A Trikalinos,et al.  The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. , 2003, Kidney international.

[122]  R. Beyaert,et al.  Structure–function analysis of the A20‐binding inhibitor of NF‐κB activation, ABIN‐1 , 2003 .

[123]  A. Tarakhovsky,et al.  Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development , 2003, Nature Immunology.

[124]  D. Isenberg,et al.  An open study of B lymphocyte depletion in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[125]  K. Koike,et al.  A new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signaling. , 2002, Biochemical and biophysical research communications.

[126]  J. Ioannidis,et al.  Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. , 2002, Arthritis and rheumatism.

[127]  J. Piette,et al.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. , 2002, Arthritis and rheumatism.

[128]  Katsuhiko Mikoshiba,et al.  BANK regulates BCR‐induced calcium mobilization by promoting tyrosine phosphorylation of IP3 receptor , 2002, The EMBO journal.

[129]  J. Harley,et al.  Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. , 2001, Arthritis and rheumatism.

[130]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[131]  K. Rajewsky,et al.  The B-Cell-Specific src-Family Kinase Blk Is Dispensable for B-Cell Development and Activation , 2000, Molecular and Cellular Biology.

[132]  J. Inoue,et al.  Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. , 2000, Experimental cell research.

[133]  E. Shaoul,et al.  Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. , 1999, Blood.

[134]  K. Sullivan.  Complement deficiency and autoimmunity. , 1998, Current opinion in pediatrics.

[135]  J. Cyster,et al.  Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. , 1998, Immunity.

[136]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[137]  Philippe Soriano,et al.  Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. , 1997, Immunity.

[138]  T. Watanabe,et al.  Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice , 1996, The Journal of experimental medicine.

[139]  T. Yamamoto,et al.  Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. , 1995, Immunity.

[140]  S. Stacker,et al.  Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.

[141]  M. Tewari,et al.  Activation of the B-cell Surface Receptor CD40 Induces A20, a Novel Zinc Finger Protein That Inhibits Apoptosis (*) , 1995, The Journal of Biological Chemistry.

[142]  M. Walport,et al.  Hereditary C1q deficiency and systemic lupus erythematosus. , 1994, QJM : monthly journal of the Association of Physicians.

[143]  O. Otsubo,et al.  Selective deficiency of C1s associated with a systemic lupus erythematosus-like syndrome. Report of a case. , 1992, Arthritis and rheumatism.

[144]  T. Mack,et al.  A revised estimate of twin concordance in systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[145]  S. Desiderio,et al.  Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. , 1990, Science.

[146]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[147]  K. Shibuya,et al.  Lupus erythematosus-like syndrome with selective complete deficiency of C1q. , 1981, Annals of internal medicine.

[148]  JOSEPH LUCAS,et al.  The Topography of Galloway , 1887, Nature.

[149]  G. Romanes.  Sense of Humour and Reason in Animals , 1875, Nature.

[150]  Hong Zhang,et al.  Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[151]  J. Rioux,et al.  A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles , 2011, Genes and Immunity.

[152]  A. Yaici,et al.  Basic and translational research , 2011 .

[153]  M. Daly,et al.  Integrating Autoimmune Risk Loci with Gene-Expression Data Identifies Specific Pathogenic Immune Cell Subsets. , 2011, American journal of human genetics.

[154]  C. Sasakawa,et al.  A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKγ to dampen the host NF-κB-mediated inflammatory response , 2010, Nature Cell Biology.

[155]  C. Gordon,et al.  Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. , 2010, Arthritis and rheumatism.

[156]  D. Isenberg,et al.  Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[157]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .

[158]  M. Walport,et al.  Complement deficiency and immune complex disease , 2005, Springer Seminars in Immunopathology.

[159]  M. McClain,et al.  Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry , 2005, Nature Medicine.

[160]  R. Longnecker,et al.  Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. , 2001, Immunity.

[161]  R. Hendriks,et al.  Role of Bruton's Tyrosine Kinase in B Cell Development , 2001, Developmental immunology.